Category Archives: Proton Pump Inhibitors

Featured Stories

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

Do Vitamin Drinks Pose Health Risks?Do Vitamin Drinks Pose Health Risks?

Do Vitamin Drinks Pose Health Risks?

Scientists are concerned vitamin drinks are contributing to levels of vitamins and other nutrients that are not only unnecessary, but potentially harmful.

Read More

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Another lawsuit has been filed over adverse Plavix side effects. The lawsuit, filed by national law firm Parker Waichman LLP, alleges that the blood thinner, Plavix (clopidogrel), caused an Oklahoma man to suffer from multiple stomach bleeds.

Read More

FDA Questions Device Makers about Duodenoscope Cleaning Procedures

Following Deadly Outbreaks, FDA Questions Device Makers about Duodenoscope Cleaning Procedures

In light of a recent outbreak linked to contaminated duodenoscopes, the U.S. Food and Drug Administration (FDA) is questioning manufacturers about their methods for cleaning the devices, the New York Times reports. The specialized scopes, which have been linked to several outbreaks in recent years, most recently infected seven patients ...

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

Warning for Medtronic InterStim Neurostimulation Devices

Australian Health Agency Issues Warning for Battery Problem with Medtronic InterStim Neurostimulation Devices

Warning for Medtronic InterStim Neurostimulation DevicesTGA has issued a safety warning for InterStim and InterStim II neurostimulation devices, because of possible early depletion of the battery.

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

Indiana Woman Alleges Serious Injuries From Transvaginal Mesh Products

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a woman who suffered injuries after receiving transvaginal mesh implants. The lawsuit suit alleges that the transvaginal mesh created an unreasonable risk and directly caused her injuries.

Read More

Metal-on-Metal Hip Replacement Device

Smith & Nephew’s Birmingham Metal-on-Metal Hip Replacement Device

Wright Medical Inc. took steps in to 2006 to convince the U.S. Food & Drug Administration (FDA) to reject pre-market approval of rival Smith & Nephew’s Birmingham metal-on-metal hip implant. Wright Medical, which makes two metal-on-metal hip replacement devices, the Conserve and the Lieneage device, filed a citizen petition ...

Read More

Proton Pump Inhibitors Raise Infection Risk in Cirrhosis Patients

Proton Pump Inhibitors (PPIs) such as Prilosec, Aciphex, Prevacid, and Protonix, raise infection risks in cirrhosis patients, according to a new study that found the risk for serious infections affects patients with decompensated cirrhosis. PPI users suffer from a 66 … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged |

Meta-Analysis Finds Proton Pump Inhibitors Increase Risk of C. Difficile-Associated Diarrhea by 69%

A newly-published study has again shown that the use of popular heartburn drugs known as proton pump inhibitors can increase the likelihood that a person will develop Clostridium difficile-associated diarrhea.  The authors of the study, which appears in the American … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged |

Study Finds “Robust” Risk of C. difficile with Proton Pump Inhibitors, other Heartburn Drugs

A new study has found that taking acid reducing drugs, including proton pump inhibitors, can significantly increase the risk for Clostridium difficile (C. difficile) infection. The lead author of the study, which involved a meta-analysis of 30 separate studies, characterized … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged |

PPI Side Effect Warnings for Fractures, Hypomagnesaemia Issued in U.K.

U.K. regulators issued two warnings this week regarding serious Proton Pump Inhibitor (PPI) side effects. According to the Medical and Healthcare Products Regulatory Agency (MHRA), recent studies indicated a link between long-term use of PPIs and fractures of the hip, … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors | Tagged |

Health Canada Warns PPIs May Cause C. Diff-Associated Diarrhea

Health Canada is warning Canadians that prescription stomach antacids called proton pump inhibitors (PPIs) may cause Clostridium difficile–associated diarrhea (CDAD). CDAD is a potentially serious gastrointestinal infection. C. diff is bacterium that can cause diarrhea and may lead to more … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

FDA Says Proton Pump Inhibitors May Cause C-difficile Diarrhea

Using popular heartburn drugs called proton pump inhibitors (PPIs) could put some users at risk of contracting Clostridium difficile–associated diarrhea (CDAD), a potentially serious gastrointestinal infection. In a Drug Safety Communication issued yesterday, the U.S. Food & Drug Administration (FDA) … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

Another Study Links Popular Heartburn Drugs to Hip Fractures

A new study is providing more evidence of an association between hip fractures in older women and the use of popular heartburn drugs known as proton pump inhibitors (PPIs). The study, published in the British Medical Journal, found that post-menopausal … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

Proton Pump Inhibitors Linked to Heart Birth Defects

Proton Pump Inhibitors (PPIs) have been being linked to heart birth defects, when taken by women in the first trimester of pregnancy, according to a recent study. Popular PPIs include Aciphex (rabeprazole), Nexium (esomeprazole), Prevacid (lansoprazole), Prilosec (omeprazole), and Protonix … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

Studies Show Many People Taking Proton Pump Inhibitors Don’t Need Them

Aciphex, Dexilant, Nexium, Prevacid, Prilosec, and Protonix, all part of a class of drugs known a < "http://www.yourlawyer.com/topics/overview/Proton_pump_inhibitors">proton pump inhibitors, may be overprescribed, some recent studies indicate. According to a report from Web MD, overuse of proton pump inhibitors, which … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

New Study Finds PPIs Increase Risk For C. Diff

Popular heartburn medications, < "http://www.yourlawyer.com/topics/overview/Proton_pump_inhibitors">Proton Pump Inhibitors (PPIs), have been linked to more adverse reactions; this time, Clostridium difficile (C. diff), in a large Japanese study presented at the annual Interscience Conference on Antimicrobial Agents and Chemotherapy. We recently wrote … Continue reading

Posted in Pharmaceuticals, Proton Pump Inhibitors |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.